Skip to main content

Due to HHS and NIH restructuring, as of March 2025, this website will be maintained, but no new content will be added.

NIAAA Spectrum banner

Canadian Official Visits Clinical Center, Learns About Alcohol Research

Image
Bar-Lab
Credit: Daniel Silber, NIH Clinical Center

The Honorable Ya’ara Saks, Minister of Mental Health and Addictions and Associate Minister of Health for Canada (left), toured the National Institutes of Health Clinical Center on Nov. 13, 2023. As part of her visit, she spoke with National Institute on Alcohol Abuse and Alcoholism (NIAAA) Deputy Clinical Director Nancy Diazgranados, M.D. (right), about NIAAA’s research, including the simulated bar laboratory that is pictured here. Researchers use this “virtual bar” to explore triggers to drinking beverages containing alcohol and to test potential new medications for alcohol treatment. 

In this Issue

Image
Doctor-Patient

Feature

Combining Screening, Brief Intervention, and Referral to Treatment With Recovery Management in Primary Care Settings Improves Outcomes

Alcohol screening, brief intervention, and referral to treatment (SBIRT) can be an effective method for identifying persons either at risk for or with alcohol-related problems and for connecting them to treatment. Recent data suggest, however, that while screening for alcohol misuse is common in primary care and other health care settings, patients are less likely to be provided a brief intervention for problematic drinking and even more unlikely to be referred to or receive treatment for alcohol use disorder (AUD).

Image
NFTF-GLP1

News from the Field

Semaglutide Shows Promise as a Potential Alcohol Use Disorder Medication

Intramural scientists at the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the National Institute on Drug Abuse (NIDA), and collaborators from The Scripps Research Institute, found that semaglutide reduces alcohol consumption and binge-like drinking in a rodent model of alcohol misuse. Published in the June 2023 issue of the journal JCI Insight, the study adds to growing preclinical evidence that the glucagon-like peptide-1 (GLP-1) system plays a role in alcohol and other substance use disorders, and that GLP-1 receptor agonists show potential for treating people with alcohol

Image
France

Noteworthy

National Institute on Alcohol Abuse and Alcoholism Signs Letter of Intent With French Science Agency

The National Institute on Alcohol Abuse and Alcoholism (NIAAA) has signed a letter of intent (LOI) with its French counterpart, Institut national de la santé et de la recherche médicale (National Institute of Health and Medical Research), also known as Inserm. 

Image
article_Youth

Noteworthy

National Institute on Alcohol Abuse and Alcoholism Releases Web Resource for Middle School

Underage drinking is a significant public health problem in the United States. As part of its efforts to raise awareness of and combat underage drinking, the National Institute on Alcohol Abuse and Alcoholism (NIAAA) has launched NIAAA for Middle School. NIAAA for Middle School is an online resource that helps parents, caregivers, and teachers introduce and reinforce key messages about peer pressure and skills for resisting it, as well as about other important topics related to underage drinking.

Looking for U.S. government information and services?
Visit USA.gov